Priya U Kumthekar – Grants — Northwestern Scholars

View Scopus Profile

Emailp-kumthekarnorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

15 Active
22 Finished

25 - 37 out of 37 results

Finished

Prot #M13-813: A Randomized, Placebo Controlled Phase 2b/3 Study of ABT-414 with Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects with Newly Diagnosed Glioblastoma (GBM) with Epidermal Growth Factor Receptor (EGFR) Amplification
Kumthekar, P. U.
AbbVie Inc.
5/17/16 → 5/17/19
Project: Research project
Alliance for Clinical Trials in Oncology (Alliance) Executive Officer
Kumthekar, P. U.
Brigham and Women's Hospital, National Cancer Institute
3/1/16 → 2/28/19
Project: Research project
Prot #ML29366: An Open-Label, Single-Arm, Phase II Study Of Pertuzumab With High-Dose Trastuzumab For The Treatment Of Central Nervous System Progression Post-Radiotherapy In Patients With Her2-Positive Metastatic Breast Cancer (Patricia)
Kumthekar, P. U.
Quintiles, Inc., Genentech, Inc.
11/6/15 → 12/31/21
Project: Research project
The ENDURES study: Environmental Dynamics Underlying Responsive Extreme Survivors of Glioblastoma
Wang, L. & Kumthekar, P. U.
Mayo Clinic Arizona, James S. McDonnell Foundation
7/1/15 → 6/30/18
Project: Research project
DRUG TPI-287-18: Phase 2 Dose-Escalation Study of TPI 287 in Combination with Bevacizumab in Adults with Recurrent or Progressive Glioblastoma Following a Bevacizumab Alone
Kumthekar, P. U.
Cortice Biosciences, Inc.
8/19/14 → 8/19/17
Project: Research project
Prot #ANG1005-CLN-04: A Phase II, Open-Label, Multi-Center Study of ANG1005 in HER2+ Breast Cancer Patients with Progressive/Recurrent Brain Metastases
Kumthekar, P. U.
AngioChem Inc.
2/10/14 → 2/10/19
Project: Research project
Prot #ANG1005-CLN-03: A Phase II, Open-Label, Multi-Center Study of ANG1005 in Patients with Recurrent High-Grade Glioma
Kumthekar, P. U.
Integrated Therapeutic Solutions, Inc., AngioChem Inc.
12/20/13 → 7/10/19
Project: Research project
Prot #M12-356: A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 in Combination with Radiation Plus Temozolomide or Temozolomide Alone for Subjects with Glioblastoma Multiforme
Kumthekar, P. U.
AbbVie Inc.
12/6/13 → 12/6/17
Project: Research project
Prot #NU 12C06: A Phase II Trial of Bevacizumab in Patients with Recurrent Solid Tumor Brain Metastases Who Have Failed Whole Brain Radiation Therapy
Kumthekar, P. U.
Genentech, Inc.
9/24/13 → 10/30/20
Project: Research project
Prot# M10-128: A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination with Whole Brain Radiation Therapy in Subjects with Brain Metastases
Kumthekar, P. U.
Abbott Laboratories
7/25/11 → 7/25/14
Project: Research project
Prot# H4320s//NU 10C03: Phase I/II Dose Escalation Trial to Assess Safety of Intrathecal Trastuzumab for the Treatment of Leptomeningeal Metastases in HER2 Positive Breast Cancer
Kumthekar, P. U., Gradishar, W. J. & Raizer, J. J.
Genentech, Inc.
4/22/11 → 12/31/20
Project: Research project
Prot # AVF4680s: Phase II Trial of Bevacizumab in Patients with Recurrent or Progressive Meningiomas
Kumthekar, P. U. & Raizer, J. J.
Genentech, Inc.
4/20/10 → 12/31/18
Project: Research project